Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment (2024)
- Authors:
- USP affiliated authors: ARCHANGELO, LETICIA FRÖHLICH - FMRP ; REIS, RODOLFO BORGES DOS - FMRP ; SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1186/s13039-024-00698-w
- Subjects: EPIGÊNESE GENÉTICA; PLATAFORMA DIGITAL; MEDICINA CLÍNICA; BIOMARCADORES; GENOMAS; BANCO DE DADOS
- Keywords: Oncogenes; Tumor suppressor genes; DNA mutational analysis; Personalized cancer treatment; Cancer biomarkers; Chemotherapy; Actionable mutations; Artificial intelligence; Big data integration; Oncology software
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular Cytogenetics
- ISSN: 1755-8166
- Volume/Número/Paginação/Ano: v. 17, n. 1, art. 28, p. 1-18, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GAZOLA, Antonia A. et al. Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment. Molecular Cytogenetics, v. 17, n. 1, p. 1-18, 2024Tradução . . Disponível em: https://doi.org/10.1186/s13039-024-00698-w. Acesso em: 28 fev. 2026. -
APA
Gazola, A. A., Dutra, W. L., Archangelo, L. F., Reis, R. B. dos, & Squire, J. A. (2024). Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment. Molecular Cytogenetics, 17( 1), 1-18. doi:10.1186/s13039-024-00698-w -
NLM
Gazola AA, Dutra WL, Archangelo LF, Reis RB dos, Squire JA. Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment [Internet]. Molecular Cytogenetics. 2024 ; 17( 1): 1-18.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1186/s13039-024-00698-w -
Vancouver
Gazola AA, Dutra WL, Archangelo LF, Reis RB dos, Squire JA. Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment [Internet]. Molecular Cytogenetics. 2024 ; 17( 1): 1-18.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1186/s13039-024-00698-w - Quantitative measurement of PTEN loss improves risk assessment in prostate cancer
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment
- Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
- Emerging role of PTEN loss in evasion of the immune response to tumours
- Effect of Uhmk1 overexpression and knockdown in murine cells
- Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]
- PIMREG (PICALM interacting mitotic regulator)
- Caracterização da superexpressão de SF1 no splicing
- UHMK1 (U2AF homology motif kinase 1)
Informações sobre o DOI: 10.1186/s13039-024-00698-w (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
